Research Output

A perspective on the developmental toxicity of inhaled nanoparticles.

  This paper aimed to clarify whether maternal inhalation of engineered nanoparticles (NP) may constitute a hazard to pregnancy and fetal development, primarily based on experimental animal studies of NP and air pollution particles. Overall, it is plausible that NP may translocate from the respiratory tract to the placenta and fetus, but also that adverse effects may occur secondarily to maternal inflammatory responses. The limited database describes several organ systems in the offspring to be potentially sensitive to maternal inhalation of particles, but large uncertainties exist about the implications for embryo–fetal development and health later in life. Clearly, the potential for hazard remains to be characterized. Considering the increased production and application of nanomaterials and related consumer products a testing strategy for NP should be established. Due to large gaps in data, significant amounts of groundwork are warranted for a testing strategy to be established on a sound scientific basis.

  • Type:

    Article

  • Date:

    30 November 2014

  • Publication Status:

    Published

  • Publisher

    Elsevier

  • DOI:

    10.1016/j.reprotox.2015.05.015

  • ISSN:

    0890-6238

  • Library of Congress:

    RM Therapeutics. Pharmacology

  • Dewey Decimal Classification:

    615 Pharmacology and therapeutics

Citation

Hougaard, K. S., Campagnolo, L., Chavatte-Palmer, P., Tarrade, A., Rousseau-Ralliard, D., Valentino, S., …Cassee, F. R. (2014). A perspective on the developmental toxicity of inhaled nanoparticles. Reproductive Toxicology. 56, 118-140. doi:10.1016/j.reprotox.2015.05.015. ISSN 0890-6238

Authors

Keywords

Nanoparticles; Nanomaterial; Ultrafine particles; Developmental toxicity; Reproductive toxicity; Inhalation; Instillation; Pregnancy;

Monthly Views:

Available Documents